Chizoba Ezepue, MD
Vascular Neurology · Bridgeton, MONPI 1568802148
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,823 of the $8,343 with a category attached, or 69.8%. 10 manufacturers reported payments, led by Stryker at 49.7% of the total.
Across 57 payments — averaging $146.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Medtronic$2K
- Cordis US CORP.$1K
- Imperative Care, Inc$257
- Penumbra, Inc.$210
- Medical Device Business Services, Inc.$140
- plus $202 from 4 others
What the payments were for
- Travel & lodging$5,82370%
- Food & beverage$2,38029%
- Education$1402%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 29 | $4,149 |
| Medtronic(2 entities) | 7 | $2,218 |
| Cordis US CORP. | 4 | $1,166 |
| Imperative Care, Inc | 4 | $257 |
| Penumbra, Inc. | 3 | $210 |
| Medical Device Business Services, Inc. | 1 | $140 |
| AbbVie | 6 | $137 |
| Inspiremd Ltd | 1 | $31 |
| Biogen | 1 | $19 |
| Microvention, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHRO SELECT$1,913
- Solitaire$1,794
- TARGET$680
- ATLAS$572
- PRECISE PRO RX$495
- TREVO$394
- Onyx$330
- SURPASS EVOLVE$307
- ZOOM 88-T LARGE DISTAL PLATFORM$187
- Penumbra System$105
How this compares
Too few vascular neurology providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $16,062 |
| ClopidogrelClopidogrel Bisulfate | 58 | $720 |
| Gabapentin | 15 | $119 |
| Atorvastatin Calcium | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Bridgeton
- Amer AlshekhleeBridgeton$4K
- Adnan QureshiColumbia$60K
- Guillermo LinaresSaint Louis$11K
- Camilo GomezColumbia$6K
- Weston GordonSaint Louis$5K
- Chike IlorahSaint Louis$5K
- Brandi FrenchColumbia$3K
- Abdallah AmirehSaint Joseph$3K
- Randall EdgellSaint Louis$687
- Firas Al ShakarchiKansas City$681
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.